Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.31 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.31 |
| ▸ | GABRP | O00591 | 1/20 | 0.31 |
| ▸ | GABRD | O14764 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.31 |
| ▸ | GABRE | P78334 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.31 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.31 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1471843 | 0.82 | — | — | |
| SCHEMBL8764246 | 0.82 | UGT2B7 (0.32) | — | |
| SCHEMBL130488 | 0.82 | — | — | |
| SCHEMBL1464686 | 0.77 | — | — | |
| SCHEMBL2511775 | 0.75 | TP53 (0.41) | PMP22LMNA | |
| SCHEMBL10524293 | 0.75 | TP53 (0.41) | PMP22LMNA | |
| SCHEMBL4253818 | 0.72 | — | — | |
| SCHEMBL7802318 | 0.72 | UGT2B7 (0.31) | — | |
| SCHEMBL6112257 | 0.71 | — | — | |
| SCHEMBL728989 | 0.71 | CPN1 (0.31) | CPN1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1215215-A1 | Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues | G.D. SEARLE & CO. (US) | 2002-06-19 | — | — | EP | disclosed |
| US-5811398-A | Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues | G. D. SEARLE & CO. (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0835265-A1 | PLATELET AGGREGATION INHIBITORS CONTAINING C-TERMINAL AMINERGIC SIDE CHAIN AMINO ACID RESIDUES | G.D. SEARLE & CO. (US) | 1998-04-15 | — | — | EP | disclosed |
| WO-1996032415-A1 | PLATELET AGGREGATION INHIBITORS CONTAINING C-TERMINAL AMINERGIC SIDE CHAIN AMINO ACID RESIDUES | G.D. SEARLE & CO. (US) | 1996-10-17 | — | — | WO | disclosed |
| EP-0577217-A1 | Tetrazolyl-(phenoxy and phenoxyalkyl) piperidininylpyridazines as antiviral agents | STERLING WINTHROP INC. (US) | 1994-01-05 | — | — | EP | disclosed |
| US-5268351-A | Containing a perhydro(iso)quinoline ring structure | BASF AKTIENGESELLSCHAFT (DE) | 1993-12-07 | — | — | US | disclosed |
| US-5242924-A | Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents | STERLING WINTHROP INC. (US) | 1993-09-07 | — | — | US | disclosed |
| US-5175295-A | Mildewicides | BASF AKTIENGESELLSCHAFT (DE) | 1992-12-29 | — | — | US | disclosed |